Intensive Consolidation With G-CSF Support: Tolerability, Safety, Reduced Hospitalization, and Efficacy in Acute Myeloid Leukemia Patients ≥60 Years

American Journal of Hematology - United States
doi 10.1002/ajh.24847
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Acute Myeloid Leukemia in Patients Older Than 60 Year

Journal of Tumor Medicine & Prevention
2018English

Phase I Study of Oral Clofarabine Consolidation in Adults Aged 60 and Older With Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

A Phase I Study of Tipifarnib Combined With Conventional Induction and Consolidation Therapy for Previously Untreated Patients With Acute Myeloid Leukemia Aged 60 Years and Over

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2008English

Clofarabine, Idarubicin, and Cytarabine (CIA) as Frontline Therapy for Patients <= 60 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Intensive Chemotherapy With Idarubicin, Cytosine Arabinoside, and Granulocyte Colony-Stimulating Factor (G-Csf) in Patients With Secondary and Therapy-Related Acute Myelogenous Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1997English

Challenges in Treating Older Patients With Acute Myeloid Leukemia

Journal of Oncology
Oncology
2010English

Clinical Efficacy and Safety of Imatinib in the Management of Ph+ Chronic Myeloid or Acute Lymphoblastic Leukemia in Chinese Patients

OncoTargets and Therapy
OncologyPharmacology
2014English

Mesenchymal Stromal Cells From Myelodysplastic and Acute Myeloid Leukemia Patients Display in Vitro Reduced Proliferative Potential and Similar Capacity to Support Leukemia Cell Survival

Stem Cell Research and Therapy
GeneticsCell BiologyMolecular BiologyBiochemistryMedicineMolecular Medicine
2018English

RAS Mutation in Acute Myeloid Leukemia Is Associated With Distinct Cytogenetic Subgroups but Does Not Influence Outcome in Patients Younger Than 60 Years

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy